Clinical Research Directory

Inclusion Criteria: * Able and willing to comprehend and follow the requirements of the study * Able and willing to provide a signed and dated Informed Consent document and HIPAA authorization * Male or female of any race or ethnicity, aged 18 years or older * Able to read and understand English * Mild to moderate symptoms of ocular surface inflammation associated with allergic conjunctivitis, dry eye disease, or following ocular surgery * History of use of topical ocular medications * Subjects of reproductive potential who agree to use a medically acceptable form of birth control during the study and for 30 days following the last dose of investigational product Exclusion Criteria: * Suspected alcohol or substance abuse (e.g., amphetamines, benzodiazepines, cocaine, marijuana, opiates) * Known sensitivity, allergies, or contraindications to any investigational product ingredient * Pregnancy * Previously screened and determined to be ineligible for the study * Use of a therapeutic eye treatment (OTC or prescription) within 2 days of the Screening/Baseline visit * Relative, partner, or staff of any clinical research site personnel * Active ocular infection of any type at the start of the study (bacterial, viral, or fungal), or positive history of ocular herpetic infection * Compromised immune system * Chronic systemic inflammatory disease (e.g., rheumatoid arthritis, Sjögren's syndrome) * Contact lens use within 24 hours prior to Visit 1 and during study participation * Use of any new ocular OTC or prescription medications within 24 hours prior to Visit 1 and throughout study participation